Schuster BG - Search Results

1

Efficacy of azithromycin as a causal prophylactic agent against murine malaria.

Andersen SL, Ager AL, McGreevy P, Schuster BG, Ellis W, Berman J. Andersen SL, et al. Among authors: schuster bg. Antimicrob Agents Chemother. 1994 Aug;38(8):1862-3. doi: 10.1128/AAC.38.8.1862. Antimicrob Agents Chemother. 1994. PMID: 7986022 Free PMC article.

2

Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo.

Andersen SL, Ager A, McGreevy P, Schuster BG, Wesche D, Kuschner R, Ohrt C, Ellis W, Rossan R, Berman J. Andersen SL, et al. Among authors: schuster bg. Am J Trop Med Hyg. 1995 Feb;52(2):159-61. doi: 10.4269/ajtmh.1995.52.159. Am J Trop Med Hyg. 1995. PMID: 7872444

3

Antimalarial activity of WR 243251, a Dihydroacridinedione.

Berman J, Brown L, Miller R, Andersen SL, McGreevy P, Schuster BG, Ellis W, Ager A, Rossan R. Berman J, et al. Among authors: schuster bg. Antimicrob Agents Chemother. 1994 Aug;38(8):1753-6. doi: 10.1128/AAC.38.8.1753. Antimicrob Agents Chemother. 1994. PMID: 7986005 Free PMC article.

4

Azithromycin prophylaxis against a chloroquine-resistant strain of Plasmodium falciparum.

Kuschner RA, Heppner DG, Andersen SL, Wellde BT, Hall T, Schneider I, Ballou WR, Foulds G, Sadoff JC, Schuster B, et al. Kuschner RA, et al. Lancet. 1994 Jun 4;343(8910):1396-7. doi: 10.1016/s0140-6736(94)92526-7. Lancet. 1994. PMID: 7910886 Clinical Trial.

5

Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers.

Anderson SL, Berman J, Kuschner R, Wesche D, Magill A, Wellde B, Schneider I, Dunne M, Schuster BG. Anderson SL, et al. Among authors: schuster bg. Ann Intern Med. 1995 Nov 15;123(10):771-3. doi: 10.7326/0003-4819-123-10-199511150-00005. Ann Intern Med. 1995. PMID: 7574195 Clinical Trial.

6

Comparison of beta-artemether and beta-arteether against malaria parasites in vitro and in vivo.

Shmuklarsky MJ, Klayman DL, Milhous WK, Kyle DE, Rossan RN, Ager AL Jr, Tang DB, Heiffer MH, Canfield CJ, Schuster BG. Shmuklarsky MJ, et al. Among authors: schuster bg. Am J Trop Med Hyg. 1993 Mar;48(3):377-84. doi: 10.4269/ajtmh.1993.48.377. Am J Trop Med Hyg. 1993. PMID: 8470775

7

Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.

Grogl M, Schuster BG, Ellis WY, Berman JD. Grogl M, et al. Among authors: schuster bg. J Parasitol. 1999 Apr;85(2):354-9. J Parasitol. 1999. PMID: 10219319

8

Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial.

Brueckner RP, Coster T, Wesche DL, Shmuklarsky M, Schuster BG. Brueckner RP, et al. Among authors: schuster bg. Antimicrob Agents Chemother. 1998 May;42(5):1293-4. doi: 10.1128/AAC.42.5.1293. Antimicrob Agents Chemother. 1998. PMID: 9593172 Free PMC article. Clinical Trial.

9

Failure of doxycycline as a causal prophylactic agent against Plasmodium falciparum malaria in healthy nonimmune volunteers.

Shmuklarsky MJ, Boudreau EF, Pang LW, Smith JI, Schneider I, Fleckenstein L, Abdelrahim MM, Canfield CJ, Schuster B. Shmuklarsky MJ, et al. Ann Intern Med. 1994 Feb 15;120(4):294-9. doi: 10.7326/0003-4819-120-4-199402150-00006. Ann Intern Med. 1994. PMID: 8291822 Clinical Trial.

10

Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi.

Dietze R, Carvalho SF, Valli LC, Berman J, Brewer T, Milhous W, Sanchez J, Schuster B, Grogl M. Dietze R, et al. Am J Trop Med Hyg. 2001 Dec;65(6):685-9. doi: 10.4269/ajtmh.2001.65.685. Am J Trop Med Hyg. 2001. PMID: 11791957 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters